DIN 02440989 — FETZIMA 40 MG
FETZIMA is a capsule (extended-release) of Levomilnacipran marketed by ABBVIE CORPORATION. The full Levomilnacipran monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02440989
- Brand name
- FETZIMA
- Active ingredient
- Levomilnacipran
- Strength
- 40 MG
- Dosage form
- CAPSULE (EXTENDED-RELEASE)
- Route
- ORAL
- Manufacturer
- ABBVIE CORPORATION
- Health Canada status
- MARKETED
- Drug class
- Serotonin-norepinephrine reuptake inhibitor (SNRI)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Levomilnacipran products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02441004 | FETZIMA | 120 MG | CAPSULE (EXTENDED-RELEASE) | ABBVIE CORPORATION | MARKETED |
| 02440970 | FETZIMA | 20 MG | CAPSULE (EXTENDED-RELEASE) | ABBVIE CORPORATION | MARKETED |
| 02440997 | FETZIMA | 80 MG | CAPSULE (EXTENDED-RELEASE) | ABBVIE CORPORATION | MARKETED |